Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TechnologyAdvice

- PMLiVE

Merck & Co’s anacetrapib data fails to generate much excitement

Treatment proves unable to reduce a composite outcome of major atherosclerotic events

Biogen Idec building

Biogen says trial extension data keep Alzheimer’s drug on track

Releases updated results from the PRIME trial of anti-amyloid drug aducanumab

- PMLiVE

EUSA receives European green light for kidney cancer treatment Fotivda

European Commission approves the drug to treat RCC

- PMLiVE

Boehringer Ingelheim launches new digital innovation team

BI X will aim to accelerate research and development

- PMLiVE

mXm launches mXm Health Consulting

Strategic consulting arm to operate alongside mXm Medical Communications

- PMLiVE

Almirall appoints Peter Guenter as its CEO

He joins from Sanofi where he was executive vice president

- PMLiVE

Germany will be first EU launch market for new Soliris indication

Alexion 'currently evaluating' additional European launches for its orphan drug

- PMLiVE

Gilead makes $11.9bn play for CAR-T specialist Kite

The agreement is due to close in this year’s fourth quarter

- PMLiVE

New EU and US approvals for Humira biosimilars

Samsung’s Imraldi and Boehringer Ingelheim’s Cyltezo receives nod from EMA and FDA, respectively

- PMLiVE

Portland Health appoints Alfred Jackson as a partner

He joins the London-headquartered agency from Spectrum

Shire promotes Joanne Cordeiro to chief human resources officer

But loses CFO Jeff Poulton, who is moving to Boston start-up Indigo

Roche Basel Switzerland

Roche wins FDA priority review for haemophilia A drug

Emicizumab prophylaxis could be approved early next year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links